ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,827.04
-1.54%
US Tech 100
20,263.20
-1.69%
다우존스 지수
41,938.45
-1.63%
Bitcoin
93,693.91
-0.84%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 유럽
  5. EU

  6. Tayninh (TAYN) 시세

Tayninh

Tayninh (TAYN)

EU
1.21
0.00
(0.00%)
마감 13 1월 1:30AM
15분 지연

개인 투자자를 위한 전문가급 도구.

프리미엄

주요 통계 및 세부정보

가격
1.21
매수가
1.21
매도가
1.78
거래량
0.00
0.00 일간 변동폭 0.00
1.21 52주 범위 1.47
market_cap
11.058M
전일 종가
1.21
개장가
-
최근 거래 시간
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
26
발행 주식
9,138,462
배당수익률
-
주가수익률
21.57
주당순이익(EPS)
0.06
매출
-
순이익
513k

Tayninh 정보

섹터
Real Estate Agents & Mgrs
산업
Real Estate Agents & Mgrs
웹사이트
www.tayninh.fr
본부
Paris, Paris, Fra
설립됨
-
Tayninh is listed in the Real Estate Agents & Mgrs sector of the 유로넥스트 (Euronext) with ticker TAYN. The last closing price for Tayninh was 1.21 €. Over the last year, Tayninh shares have traded in a share price range of 1.21 € to 1.47 €.

Tayninh currently has 9,138,462 shares in issue. The market capitalisation of Tayninh is 11.06 € million. Tayninh has a price to earnings ratio (PE ratio) of 21.57.

TAYN 최신 뉴스

추가 뉴스

SOCIETE DE TAYNINH : MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL

SOCIETE DE TAYNINH : MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL SOCIETE DE TAYNINH Paris, le 26 septembre 2024 COMMUNIQUE DE PRESSE MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL...

27 9월 2024
UK Regulatory

MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES A L'ASSEMBLEE GENERALE MIXTE DU 13 JUIN 2024

MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES A L'ASSEMBLEE GENERALE MIXTE DU 13 JUIN 2024 SOCIETE DE TAYNINH Paris, le 23 mai 2024 COMMUNIQUÉ MODALITÉS DE MISE À...

24 5월 2024
GlobeNewswire Inc.

SOCIETE DE TAYNINH : RESULTATS ANNUELS 2023

SOCIETE DE TAYNINH : RESULTATS ANNUELS 2023 SOCIETE DE TAYNINH Paris, le 24 avril 2024 COMMUNIQUE DE PRESSE RESULTATS ANNUELS 2023 Le Conseil d’administration de la Société de Tayninh...

25 4월 2024
GlobeNewswire Inc.

SOCIETE DE TAYNINH : MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL

SOCIETE DE TAYNINH : MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL SOCIETE DE TAYNINH       Paris, le 25 septembre 2023   COMMUNIQUE DE PRESSE       MISE A DISPOSITION DU...

26 9월 2023
GlobeNewswire Inc.

MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES A L'ASSEMBLEE GENERALE ORDINAIRE DU 12 JUIN 2023

MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES A L'ASSEMBLEE GENERALE ORDINAIRE DU 12 JUIN 2023 SOCIETE DE TAYNINH       Paris, le 22 mai 2023     COMMUNIQUE    ...

23 5월 2023
GlobeNewswire Inc.

SOCIETE DE TAYNINH : RESULTATS ANNUELS 2022

SOCIETE DE TAYNINH : RESULTATS ANNUELS 2022 SOCIETE DE TAYNINH       Paris, le 26 avril 2023     COMMUNIQUE DE PRESSE       RESULTATS ANNUELS 2022     Le Conseil...

27 4월 2023
GlobeNewswire Inc.

SOCIETE DE TAYNINH : MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL

SOCIETE DE TAYNINH : MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL SOCIETE DE TAYNINH       Paris, le 19 septembre 2022   COMMUNIQUE DE PRESSE       MISE A DISPOSITION DU...

20 9월 2022
GlobeNewswire Inc.

MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES A L'ASSEMBLEE GENERALE MIXTE DU 8 JUIN 2022

MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES A L'ASSEMBLEE GENERALE MIXTE DU 8 JUIN 2022 SOCIETE DE TAYNINH       Paris, le 18 mai 2022     COMMUNIQUE    ...

19 5월 2022
GlobeNewswire Inc.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1001.211.211.2100DE
4001.211.211.2101.21DE
12001.211.471.21261.21160825DE
26-0.17-12.31884057971.381.471.21131.21145794DE
52001.211.471.2181.24297686DE
156-0.23-15.97222222221.441.471.21131.31526408DE
2600.1312.0370370371.081.81.05141.42829549DE

TAYN - Frequently Asked Questions (FAQ)

What is the current Tayninh share price?
The current share price of Tayninh is 1.21 €
How many Tayninh shares are in issue?
Tayninh has 9,138,462 shares in issue
What is the market cap of Tayninh?
The market capitalisation of Tayninh is EUR 11.06M
What is the 1 year trading range for Tayninh share price?
Tayninh has traded in the range of 1.21 € to 1.47 € during the past year
What is the PE ratio of Tayninh?
The price to earnings ratio of Tayninh is 21.57
What is the reporting currency for Tayninh?
Tayninh reports financial results in EUR
What is the latest annual profit for Tayninh?
The latest annual profit of Tayninh is EUR 513k
What is the registered address of Tayninh?
The registered address for Tayninh is 7 PLACE DU CHANCELIER ADENAUER, PARIS, PARIS, 75016
What is the Tayninh website address?
The website address for Tayninh is www.tayninh.fr
Which industry sector does Tayninh operate in?
Tayninh operates in the REAL ESTATE AGENTS & MGRS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ABCAABC Arbitrage
4.78 €
(0.00%)
0
ABAb Science
1.696 €
(0.00%)
0
AALBAalberts NV
33.24 €
(0.00%)
0
AAAAlan Allman Associates
7.45 €
(0.00%)
0
74SW74Software SA
27.00 €
(0.00%)
0
ABCAABC Arbitrage
4.78 €
(0.00%)
0
ABAb Science
1.696 €
(0.00%)
0
AALBAalberts NV
33.24 €
(0.00%)
0
AAAAlan Allman Associates
7.45 €
(0.00%)
0
74SW74Software SA
27.00 €
(0.00%)
0
ABCAABC Arbitrage
4.78 €
(0.00%)
0
ABAb Science
1.696 €
(0.00%)
0
AALBAalberts NV
33.24 €
(0.00%)
0
AAAAlan Allman Associates
7.45 €
(0.00%)
0
74SW74Software SA
27.00 €
(0.00%)
0

토론

전체 피드 보기
IVRT IVRT 11 분 전
In my opinion, there will likely be significant pressure on the share price leading up to the conference call. A sell-off could occur the day before, with the stock potentially bottoming out by the end of the investor call. I could be wrong, but I've seen similar patterns many times over the past 25
BMXI
DewDiligence DewDiligence 11 분 전
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

ENTA
DewDiligence DewDiligence 12 분 전
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

Guido2 Guido2 13 분 전
This is DUE DILIGENCE! Thank you Free Fannie.

https://x.com/freefannie/status/1878655047715991552?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ
FNMA
StockItOut StockItOut 20 분 전
That Xeriant PR excellently written with bullshit:

""After successfully completing 75% of the demanding NFPA 286 test," meaning = "after failing the NFPA 286 test by missing 25% of the approval target testing requirement,"

"the Company used the data to make several key
XERI
gitreal gitreal 23 분 전
You were actually partially right....BMXI has filed some SEC documents, some necessary (Form 1-A), some unnecessary (Form 4). And they do summarize a lot of the stuff that I think are fabrications....their production, mining operations, etc. Time will tell, but I think a lot of it (and probably
BMXI
RichieBoy RichieBoy 29 분 전
Jim wrote a blurb about seeking more US business.

Help you out any? 🤨
AFFU
DesktopDR DesktopDR 30 분 전
Any news or updates?
VPLM
Tahoe2468 Tahoe2468 33 분 전
.0915 by Thursday....... 
KRTL
skitahoe skitahoe 34 분 전
Remember GBM was redefined during the trial, thus some who were treated then had other forms of brain cancer. I believe the least we'll see in our label is brain cancer. Certainly GBM may be the deadliest of them, but treatment should work in all of them.

According to Google, GBM ha
NWBO
fuagf fuagf 41 분 전
You are right about the crafty, evil, smart. Authoritarian methods have been in full view
in capturing America. While we work to do the right things they plot to capture the lot.
facts_matter14 facts_matter14 41 분 전
If there weren’t suckers born every minute, there wouldn’t be POSRMX bag holders down as much as 99%, and there sure as hell wouldn’t be anybody believing there is a pipeline of products.






.
SRMX
StockItOut StockItOut 44 분 전
Your "closer" keeps getting extended. Then again extended. Then again extended. -- Consider that end. Now expired, horizon end now reached, and the view clarifies and we see it to be your desperation from years ago ongoing still, to pump this at any expense, where you attempt to instill FOMO to hold
XERI
fuagf fuagf 45 분 전
He would smother any question with words.
Shawonsarker84 Shawonsarker84 47 분 전
$HMBL Sorry HMBL investors. XTIA now broke the record 2.7B share volume traded before the reverse split.



https://x.com/shawonsarker84/status/1878696680088019193?t=rZlhkn2Jos4vWKxxQgXGfA&s=19
HMBL XTIA
chen1992 chen1992 49 분 전
https://www.energy.senate.gov/hearings/2025/1/hearing-to-consider-the-nomination-of-mr-chris-wright-to-be-secretary-of-energy

https://www.commerce.senate.gov/2025/1/full-committee-nomination-hearing_2#:~:text=U.S.%20Senator%20Ted%20Cruz%20(R,Wednesday%2C%20January%2015%2C%20
TGLO
FNM500K FNM500K 52 분 전
Oh noooooo.....
FNMA
StockItOut StockItOut 54 분 전
OTC filings and attorney statements. my error.

Point that it is on you to prove your claim, that:
"There's no contract employees. There's no production shafts."

Likewise for the company to do so, as we wait for an audit, apparently indefinitely.

I
BMXI
Money4Nothing-M4N Money4Nothing-M4N 1 시간 전
Definitely excited to hear about batch 5. I believe we should hear news very soon. if they began batch 5 immediately after batch 4 then 5 is overdue.

And in light of last week's PR about Darwin's Bark Dragline silk, I'm expecting KBLB to have the attention of the DOD once again.
KBLB
rx7171 rx7171 1 시간 전
Too bad no mention of the degree of brain atrophy of the Blar treated patients reverting to close to normal aging compared to the MAB treated patients having accelerated rate of atrophy.

To me this is a bio marker that sets the two therapies at extreme ends of the plus minus continuum
AVXL
Louinjaxxx Louinjaxxx 1 시간 전
The reversal on Friday just reflects the entire market downturn on Friday.
AXXA
Steady_T Steady_T 1 시간 전
That sounds pretty optimistic to me. I'd think that the RA would like to see some data on other cancers before such a broad scope label.
NWBO
boi568 boi568 1 시간 전
I think he edited the question he asked to make it look neutral.
AVXL
Louinjaxxx Louinjaxxx 1 시간 전
So the extra 5 to 6 million shares will help you pay the taxes on you gain?  That makes sense.
AXXA

최근 히스토리

EU
TAYN
Tayninh
BIT
UC7F6M
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유